Document is current
Any future updates will be listed below
-
Authors
Aiyegbusi, Olalekan Lee https://orcid.org/0000-0001-9122-8251
di Ruffano, Lavinia Ferrante
Retzer, Ameeta
Newsome, Philip N.
Buckley, Christopher D.
Calvert, Melanie J.
-
Funding
Funding for this research was provided by:
National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre (BRC-1215-20009)
- License Information
-
More Information
Article History
Received: 4 September 2020
Accepted: 4 January 2022
First Online: 15 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: OLA, PNN and MC were supported by the National Institute of Health Research (NIHR) Biomedical Research Centre (BRC), West Midlands, Birmingham. OLA also receives funding from the Health Foundation and personal fees from Gilead Sciences Ltd.MC is an NIHR Senior Investigator and reports grants from UKRI, NIHR, Macmillan Cancer Support, PCORI, Innovate UK, NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC), NIHR Applied Research Collaborative, West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, HDRUK, Gilead, GSK and Janssen and personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Glaukos, GSK and Daiichi Sankyo outside the submitted work. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
